Navigation Links
China Botanic Pharmaceutical Enters into Research Cooperation with Key Laboratory of Forest Plant Ecology
Date:9/1/2011

HARBIN, China, Sept. 1, 2011 /PRNewswire-Asia/ -- China Botanic Pharmaceutical Inc. (NYSE AMEX: CBP) ("China Botanic" or the "Company"), a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines ("TCM") in China, today announced that the Company's wholly-owned subsidiary Renhuang Pharmaceutial Limited has established a key research laboratory ("the laboratory") in cooperation with Key Laboratory of Forest Plant Ecology (KLP), which is sponsored by Ministry of Education and supported by Northeastern Forest University.

The primary purpose of the key research laboratory is to explore advanced technologies, including the cultivation of bio-active substance technology and environmentally friendly multi-level biological use of technology. The laboratory will apply such advanced techniques to improve and enhance the manufacturing process of China Botanic's fine-processed products such as Siberian Ginseng Lyophilized Syringin Powder and Total Flavonoids capsules. KLP and China Botanic aim to add value to all processes, including planting, collection, processing, research and development, and production. The cooperation with KLP will allow China Botanic to share its research resources and personnel with KLP, which will continue to provide research ideas and opportunities to the Company.

"We are pleased to enter into research cooperation with KLP, a leading plant research laboratory," said Mr. Shaoming Li, Chairman and Chief Executive Officer of China Botanic. "We believe the setting up of a key research laboratory will be beneficial to both China Botanic and KLP. This reflects on our effort to provide our customers with excellent products. We will continue to strive to collaborate with similar institutions to deliver advanced products to our customers."  

About the Key Laboratory of Forest Plant Ecology (KLP) The key Laboratory of Forest Plant Ecology (KLP) was formed in 1992. It is sponsored by Ministry of Education of China and is supported by Northeast Forestry University. In its first decade, KLP's activity centered on forest plant research fields of Botany, Ecology and Molecular Biology such as Synecology, Molecular Ecology and Calculation Ecology. In recent years, its main focus is on Forest vegetation Ecological Conservation and Biology Resources Ecological Use. Since 2000, it has undertaken a total of 92 research projects including 22 national research projects, published 220 academic papers and obtained 18 independent intellectual property rights.

ABOUT CHINA BOTANIC PHARMACEUTICAL INC.China Botanic Pharmaceutical Inc. is engaged in the research, development, manufacturing, and distribution of botanical products, bio-pharmaceutical products, and traditional Chinese medicines ("TCM"), in the People's Republic of China. All of the Company's products are produced at its three GMP-certified production facilities in Ah City, Dongfanghong and Qingyang. The Company distributes its botanical anti-depression and nerve-regulation products, biopharmaceutical products, and botanical antibiotic and OTC TCMs through its network of over 3,000 distributors and over 70 sales centers across 24 provinces in China. For more information, please visit www.renhuang.com.

Safe Harbor StatementThis press release contains certain statements that may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are based upon management's beliefs, assumptions and expectations of the Company's future operations and financial performance, taking into account the information currently available to management. These statements are not statements of historical fact. Forward-looking statements involve risks and uncertainties, some of which are not currently known that may cause actual results, performance or financial condition to be materially different from the expectations of future results, performance or financial condition expressed or implied in any forward-looking statements. These forward-looking statements are based on current plans and expectations and are subject to a number of uncertainties including, but not limited to, the Company's ability to manage expansion of its operations effectively, and other factors detailed in the Company's annual report on Form 10-K and other filings with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. You are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented herein.Company Contact:

CCG Investor Relations:China Botanic Pharmaceutical Inc.

Mr. Mark Collinson, PartnerMs. Portia Tan, IR Contact

Phone: +1-310-954-1343 (Los Angeles)Tel: 86-451-8260-2162

Email: mark.collinson@ccgir.com Email: ir@renhuang.com

Website: www.ccgirasia.com Mr. Crocker Coulson, PresidentPhone: +1-646-213-1915 (New York)Email: crocker.coulson@ccgir.com
'/>"/>

SOURCE China Botanic Pharmaceutical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. China Nuvo Solar Target Acquisition SurgLine Reports on Marketing Progress
2. China Nepstar Chain Drugstore Announces Share Repurchase Program
3. China Nepstar Chain Drugstore Reports Second Quarter 2011 Financial Results
4. China Nepstar Chain Drugstore Announces Management Change
5. China Medicine Corporation Dismisses Frazer Frost as Auditor
6. VacChina 2011 - Bridging the China Vaccine Industry with the World Class Biotechnologies
7. China Contract Research Organization (CRO) Industry Report, 2010-2011
8. Abbott Expanding Manufacturing Capacity in China to Meet Demands of Fast-Growing Nutrition Market
9. China Nuvo Solar Target Acquisition SurgLine Updates OptiMedical Corp.s Sales Forecast in Excess of $10,000,000
10. China Medical Technologies Reports First Fiscal Quarter Financial Results
11. Chairman of Global Guide to COPD Diagnosis Committee Visited West China Hospital
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016 Research and Markets ... for Companion Diagnostic Tests" report to their offering. ... Companion Diagnostics The World Market for Companion ... medicine diagnostics. Market analysis in the report includes the following: ... (In Vitro Diagnostic Kits) by Region (N. America, EU, ROW), ...
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... 2016 Research and Markets has ... by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), ... Parenteral) - Global Forecast to 2021" report to ... The global pharmaceutical excipients market is projected to reach ... 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... 27, 2016 , ... Quality metrics are proliferating in cancer care, and are ... the eye of the beholder, according to experts who offered insights and commentary in ... Managed Care. For the full issue, click here . , For the American ...
(Date:6/26/2016)... ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal trainer ... through a fitness app. The fitness app plans to fix the two major problems leading ... a one size fits all type program , They don’t eliminate all the ...
(Date:6/25/2016)... ... ... The temporary closing of Bruton Memorial Library on June 21 due to a possible lice ... overlooked aspect of head lice: the parasite’s ability to live away from a human host, ... a necessary one in the event that lice have simply gotten out of control. , ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a ... area —Johnson is one of the first doctors to perform the treatment. Orthobiologics ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
Breaking Medicine News(10 mins):